Press release
Bioabsorbable Stents Market Insights, Potential Business Strategies, Mergers and Acquisitions, Revenue Analysis
Access report overview: https://www.psmarketresearch.com/market-analysis/bioabsorbable-stents-market
The stringent government regulations for the approval of bioabsorbable stent, and high risk of side-effects associated with the implantation of stents in the body are some of the common factors, restraining the growth of the global bioabsorbable stents market. Moreover, the lack of awareness towards innovative and interventional applications of bioabsorbable stents, and lack of reimbursement policies are also hindering the growth of the bioabsorbable stents market, especially in the developing countries. However countries, such as India and China are expected to witness a considerable growth during the forecast period, owing to increasing aging population and growing incidences of CVDs.
Download Free Sample of This Research Report : https://www.psmarketresearch.com/market-analysis/bioabsorbable-stents-market/report-sample
Geographically, Europe leads the global bioabsorbable stents market, due to increasing awareness about therapeutic applications of stent technology in the treatment of CVDs. In addition, the huge investment by key players for the development of biodegradable stents and rapid product approval are propelling the growth of the bioabsorbable stents market in the region. The Asia-Pacific bioabsorbable stents market is growing with a significant rate, owing to increasing aging population and increasing prevalence of CVDs.
Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=bioabsorbable-stents-market
Some of the major players operating in global bioabsorbable stents market include, Zorion Medical, Tepha, S3V Vascular Technologies, REVA Medical, Medlogics Device Corporation, Kyoto Medical Planning, ICON Interventional Systems, Elixir Medical Corporation, Biotronik, Arterial Remodelling Technologies Arterius, Amaranth Medical, and Abbott Vascular.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioabsorbable Stents Market Insights, Potential Business Strategies, Mergers and Acquisitions, Revenue Analysis here
News-ID: 1279553 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for CVDs
Global Cardiovascular Diagnostic & Monitoring Devices Market to Reach Over USD 2 …
The global cardiovascular diagnostic & monitoring devices market, valued at USD 14.2 billion in 2021, is projected to nearly double to over USD 29.0 billion by the end of 2031, expanding at a robust CAGR of 7.5% over the forecast period (2022-2031). Fueled by the surging burden of chronic cardiovascular diseases (CVDs), demand for early diagnosis, and rapid technological advancements including AI‐enabled monitors and minimally invasive implants the market presents…
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecu …
"The contrast-enhanced ultrasound market is projected to grow at a CAGR of 6.1% during the forecast period (2023-2028)."
The global contrast-enhanced ultrasound market is projected to reach USD 2.1 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. Factors such as rising geriatric population and increasing use of contrast agents are responsible for the increasing growth of this market. Increasing research and…
RAS-acting Agents Market to Reach US$ 13.4 Billion by 2031 Due to Increase in pr …
The global 𝗥𝗔𝗦-𝗮𝗰𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗻𝘁𝘀 market is estimated to attain a valuation of US$ 13.4 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.2% during the forecast period, 2023-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by R …
According to the latest report by IMARC Group, titled "Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.80 Billion by 2027, exhibiting at a CAGR of 10.09% during 2022-2027. A ventricular assist device (VAD), also called a mechanical circulatory…
Rising Prevalence of CVDs Leads to Increasing Demand for Cardiac Biomarkers
In 2021, the cardiac biomarkers industry contributes $8,459.6 million, and it is projected to rise at a rate of 10.5%, to capture $20,718.8 million revenue in 2030. It is led by the rising prevalence of acute coronary syndrome, increasing point-of-care testing kit demand, and technological advancements in the industry.
Moreover, the surging investments in biomarker research, increasing CVDs incidences, and rising geriatric population are projected to boost the industry growth.…
Global rise in the incidence and prevalence rate of cardiovascular diseases (CVD …
Global Cardiovascular Information Systems (Cvis) Market is projected to grow at a considerable growth rate owing to increasing prevalence of CVDs across the globe. According to WHO, in 2018, CVDs accounts for 17.7 million mortality per year, which means 31% mortalities across the globe. The CVIS systems support in the assessment of chronic conditions such as CHD (coronary heart disease), stroke, and other heart related disease. CVIS systems allow assembling…
